Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MYRIAM VIJIL MEJIA

NPI
1871272732
CMS profile
11551683
Location
LUBBOCK, TX

General Payments · PY2023–2024

$1,182.69

  • Reported across 24 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$814.00

20 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $814.00 20

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $368.69 4
PY2024 $814.00 20

Payment records · PY2024 (20)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alexion Pharmaceuticals, Inc. $125.17 09/19/2024 Food and Beverage Undisputed 01/23/2026 1110514310 CMS
EMD Serono, Inc. $125.01 01/24/2024 Food and Beverage Undisputed 01/23/2026 1120213054 CMS
GENZYME CORPORATION $54.13 03/27/2024 Food and Beverage Undisputed 01/23/2026 1139842467 CMS
Novartis Pharmaceuticals Corporation $116.72 10/23/2024 Food and Beverage Undisputed 01/23/2026 1087440552 CMS
Novartis Pharmaceuticals Corporation $23.61 10/24/2024 Food and Beverage Undisputed 01/23/2026 1087440548 CMS
Teva Pharmaceuticals USA, Inc. $93.11 05/16/2024 Food and Beverage Undisputed 01/23/2026 1151481524 CMS
TG Therapeutics, Inc. $122.79 01/08/2024 Food and Beverage Undisputed 01/23/2026 1136881813 CMS
UCB, Inc. $18.38 04/16/2024 Food and Beverage Undisputed 01/23/2026 1143188442 CMS
UCB, Inc. $2.22 07/22/2024 Food and Beverage Undisputed 01/23/2026 1143168248 CMS
UCB, Inc. $25.46 07/23/2024 Food and Beverage Undisputed 01/23/2026 1143168250 CMS
UCB, Inc. $1.61 08/20/2024 Food and Beverage Undisputed 01/23/2026 1143168252 CMS
UCB, Inc. $15.66 08/20/2024 Food and Beverage Undisputed 01/23/2026 1143168254 CMS
UCB, Inc. $1.77 09/23/2024 Food and Beverage Undisputed 01/23/2026 1143168256 CMS
UCB, Inc. $22.97 09/24/2024 Food and Beverage Undisputed 01/23/2026 1143168258 CMS
UCB, Inc. $1.61 10/22/2024 Food and Beverage Undisputed 01/23/2026 1143168260 CMS
UCB, Inc. $18.67 10/22/2024 Food and Beverage Undisputed 01/23/2026 1143168262 CMS
UCB, Inc. $1.83 11/11/2024 Food and Beverage Undisputed 01/23/2026 1143168264 CMS
UCB, Inc. $26.17 11/12/2024 Food and Beverage Undisputed 01/23/2026 1143168266 CMS
UCB, Inc. $1.66 12/10/2024 Food and Beverage Undisputed 01/23/2026 1143168268 CMS
UCB, Inc. $15.45 12/10/2024 Food and Beverage Undisputed 01/23/2026 1143168270 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.